Eam Investors, LLC Curis Inc Transaction History

Eam Investors, LLC

  • $556 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$7.45 - $16.27 $699,778 - $1.53 Million
-93,930 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$8.78 - $12.8 $365,985 - $533,555
-41,684 Reduced 30.74%
93,930 $1.06 Million
Q4 2020

Feb 11, 2021
BUY
$1.08 - $8.2 $146,463 - $1.11 Million
135,614 New
135,614 $1.11 Million

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email